Cargando…

Antithrombotic Treatments in Patients with Chronic Coronary Artery Disease or Peripheral Artery Disease: A Systematic Review of Randomised Controlled Trials

AIMS: Acetylsalicylic acid (ASA) is widely used for the prevention of atherothrombotic events in patients with chronic coronary artery disease (CAD) and peripheral artery disease (PAD), but the risk of vascular events remains high. We aimed at identifying randomised controlled trials (RCTs) on antit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bauersachs, Rupert, Wu, Olivia, Briere, Jean-Baptiste, Bowrin, Kevin, Borkowska, Katarzyna, Jakubowska, Anna, Taieb, Vanessa, Toumi, Mondher, Huelsebeck, Maria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2020
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7345917/ https://www.ncbi.nlm.nih.gov/pubmed/32695228 http://dx.doi.org/10.1155/2020/3057168

Ejemplares similares

Burden of Coronary Artery Disease and Peripheral Artery Disease: A Literature Review
por: Bauersachs, Rupert, et al.
Publicado: (2019)

Assessment of the burden of disease for patients with peripheral artery disease undergoing revascularization in England
por: Portas, Laura, et al.
Publicado: (2022)

Cost-Effectiveness of Coronary and Peripheral Artery Disease Antithrombotic Treatments in Finland
por: Soini, Erkki, et al.
Publicado: (2020)

Efficacy and Safety of Rivaroxaban Compared with Other Therapies Used in Patients with Peripheral Artery Disease Undergoing Peripheral Revascularization: A Systematic Literature Review and Network Meta-Analysis
por: Bauersachs, Rupert, et al.
Publicado: (2021)

Health economic evaluation of rivaroxaban in the treatment of patients with chronic coronary artery disease or peripheral artery disease
por: Cowie, Martin R, et al.
Publicado: (2020)

Meta-analysis of real-world evidence comparing non-vitamin K antagonist oral anticoagulants with vitamin K antagonists for the treatment of patients with non-valvular atrial fibrillation
por: Coleman, Craig I., et al.
Publicado: (2019)

Antithrombotic therapy in peripheral arterial disease
por: Espinola-Klein, Christine, et al.
Publicado: (2022)

Real-world cost-effectiveness of rivaroxaban and apixaban vs VKA in stroke prevention in non-valvular atrial fibrillation in the UK
por: Bowrin, Kevin, et al.
Publicado: (2020)

Estimation of the costs attributable to vitamin K antagonist treatment in patients with non-valvular atrial fibrillation from a French societal perspective
por: Levy, Pierre, et al.
Publicado: (2019)

Antithrombotic Treatment in Lower Extremity Peripheral Arterial Disease
por: Gottsäter, Anders
Publicado: (2021)

Real-world cost-effectiveness of rivaroxaban compared with vitamin K antagonists in the context of stroke prevention in atrial fibrillation in France
por: Bowrin, Kevin, et al.
Publicado: (2020)

Antithrombotic treatment patterns in patients with atrial fibrillation in Italy pre- and post-DOACs: the REPAIR study
por: Esposti, Luca D, et al.
Publicado: (2019)

Antithrombotic Therapy in Peripheral Artery Disease: Current Evidence and Future Directions
por: Canonico, Mario Enrico, et al.
Publicado: (2023)

Antithrombotic therapy in coronary artery disease patients with atrial fibrillation
por: Wei, Lili, et al.
Publicado: (2020)

Antithrombotic therapy in patients with atrial fibrillation and coronary artery disease
por: Moustafa, Abdelmoniem, et al.
Publicado: (2019)

Antithrombotic Therapy in Patients with Coronary Artery Disease and Prior Stroke
por: Bellettini, Elisa, et al.
Publicado: (2021)

Antithrombotic Therapy in Patients with Peripheral Artery Disease: A Focused Review on Oral Anticoagulation
por: Rivera-Caravaca, José Miguel, et al.
Publicado: (2021)

Impact of Antithrombotic Therapy in Atrial Fibrillation on the Presentation of Coronary Artery Disease
por: Chan, Pak Hei, et al.
Publicado: (2015)

Characteristics of doctor-shoppers: a systematic literature review
por: Biernikiewicz, Małgorzata, et al.
Publicado: (2019)

Antithrombotic Therapy for Symptomatic Peripheral Arterial Disease: A Systematic Review and Network Meta-Analysis
por: Willems, Loes H., et al.
Publicado: (2022)

Correction to: Antithrombotic Therapy for Symptomatic Peripheral Arterial Disease: A Systematic Review and Network Meta-Analysis
por: Willems, Loes H., et al.
Publicado: (2022)

Antithrombotic Therapy for Chronic Kidney Disease Patients With Concomitant Atrial Fibrillation and Coronary Artery Disease
por: Lee, Kuo-Hua, et al.
Publicado: (2021)

Real-world cost-effectiveness analysis of NOACs versus VKA for stroke prevention in Spain
por: Escobar Cervantes, Carlos, et al.
Publicado: (2022)

Advances in the Treatment of Stable Coronary Artery Disease and Peripheral Artery Disease
por: Gibler, W. Brian
Publicado: (2018)

Antithrombotic Therapy for Percutaneous Cardiovascular Interventions: From Coronary Artery Disease to Structural Heart Interventions
por: Caracciolo, Alessandro, et al.
Publicado: (2019)

Net clinical benefit of antithrombotic therapy for atrial fibrillation patients with stable coronary artery disease
por: Lee, So-Ryoung, et al.
Publicado: (2022)

Antithrombotic regimens in females with symptomatic lower extremity peripheral arterial disease: protocol for a systematic review and meta-analysis
por: Strauss, Shira A, et al.
Publicado: (2021)

Antithrombotic drugs for cardiovascular risk reduction in patients with lower limb peripheral arterial disease: protocol for a systematic review and network meta-analysis of randomised controlled trials
por: Sidebottom, David Brooke, et al.
Publicado: (2023)

Angina due to obstructive coronary artery disease in association with peripheral artery disease
por: Mutlu, Bulent, et al.
Publicado: (2019)

Burden and Prevention of Adverse Cardiac Events in Patients with Concomitant Chronic Heart Failure and Coronary Artery Disease: A Literature Review
por: Lavoie, Louis, et al.
Publicado: (2016)

Antithrombotic Treatment Patterns of Patients with Symptomatic Peripheral Arterial Occlusive Disease in Germany: Evidence from Health Insurance Claims Data
por: Peters, Frederik, et al.
Publicado: (2022)

Peripheral Artery Disease as a Predictor of Coronary Artery Disease in Patients Undergoing Coronary Angiography
por: Kumar, Ashok, et al.
Publicado: (2021)

Moyamoya Disease with Peripheral Pulmonary Artery Stenoses and Coronary Artery Fistulae
por: Reardon, Lindsay, et al.
Publicado: (2009)

Soluble RAGE Plasma Levels in Patients with Coronary Artery Disease and Peripheral Artery Disease
por: Falcone, Colomba, et al.
Publicado: (2013)

The Complexity of Peripheral Arterial Disease and Coronary Artery Disease in Diabetic Patients: An Observational Study
por: Aly, Khaled, et al.
Publicado: (2023)

Effectiveness and Safety of Nonvitamin K Oral Anticoagulants Rivaroxaban and Apixaban in Patients with Venous Thromboembolism: A Meta-Analysis of Real-World Studies
por: Wu, Olivia, et al.
Publicado: (2022)

Medial artery calcification in peripheral artery disease
por: Kim, Tanner I., et al.
Publicado: (2023)

Therapeutic angiogenesis-based strategy for peripheral artery disease
por: Han, Jingxuan, et al.
Publicado: (2022)

Comparison of Cardiovascular Risk Factors for Peripheral Artery Disease and Coronary Artery Disease in the Korean Population
por: Jang, Shin Yi, et al.
Publicado: (2013)

A cross-sectional study on coronary artery disease diagnosis in patients with peripheral artery disease
por: Bhalke, Jai Bharat, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_f3rijsgn7pgaghfkjmkeaa5h56